49.4000.65% ( +0.320 )
Delay Closed: Oct 28, 16:00:00 (EDT)Current ValuationThe current P/E ratio is 64.80, above the reasonable range, cheaper than 2.17% of the time in the past 3 years, and the industry ranks 40/174, the industry Median -0.74.
64.8xP/E
$49.40Stock price
$0.76Earnings per share
64.8xP/E
Stock price$49.40Earnings per share$0.76
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 50.88x
- Typical range
- 44.83x–57.19x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
017345168
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
CHEOYUSCochlear Limited | 64.80x | -- | $6.46B |
IARTUSIntegra LifeSciences | 73.20x | 107.27% | $952.59M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
